Tibet Weixinkang Medicine Co., Ltd. (SHA:603676)

Tibet Weixinkang Medicine Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,942	4,330	4,539	6,928	4,051	3,803
Market Cap Growth	17.19%	-4.60%	-34.48%	71.03%	6.52%	-15.27%
Enterprise Value	3,933	3,282	3,710	6,150	3,412	3,260
Last Close Price	11.43	9.67	9.64	14.47	8.30	7.94
PE Ratio	22.05	17.59	21.21	39.15	42.23	65.09
PS Ratio	4.23	3.33	3.43	4.95	3.92	5.31
PB Ratio	3.24	3.13	3.39	5.68	3.80	3.87
P/TBV Ratio	3.29	3.16	3.48	5.79	3.84	3.94
P/FCF Ratio	40.20	13.76	26.65	41.12	35.20	47.93
P/OCF Ratio	25.37	11.62	18.82	28.14	23.73	28.44
EV/Sales Ratio	3.37	2.52	2.81	4.40	3.30	4.56
EV/EBITDA Ratio	13.01	12.23	19.75	32.23	27.40	47.58
EV/EBIT Ratio	15.95	14.78	25.58	39.80	36.72	87.09
EV/FCF Ratio	31.99	10.43	21.79	36.51	29.64	41.08
Debt / Equity Ratio	0.01	0.00	0.01	0.01	0.01	-
Debt / EBITDA Ratio	0.03	0.02	0.04	0.03	0.04	-
Debt / FCF Ratio	0.07	0.02	0.05	0.03	0.04	-
Asset Turnover	0.61	0.72	0.77	0.89	0.72	0.54
Inventory Turnover	11.68	15.05	18.37	24.34	22.67	21.56
Quick Ratio	3.58	2.79	2.73	2.50	2.16	2.18
Current Ratio	4.07	3.08	3.04	2.77	2.41	2.43
Return on Equity (ROE)	14.76%	18.06%	16.71%	15.47%	9.35%	6.11%
Return on Assets (ROA)	8.02%	7.64%	5.27%	6.11%	4.07%	1.76%
Return on Invested Capital (ROIC)	40.59%	47.92%	32.94%	38.42%	20.19%	7.77%
Return on Capital Employed (ROCE)	15.60%	15.60%	10.50%	12.30%	8.60%	3.80%
Earnings Yield	4.49%	5.68%	4.71%	2.55%	2.37%	1.54%
FCF Yield	2.49%	7.27%	3.75%	2.43%	2.84%	2.09%
Dividend Yield	2.86%	3.54%	2.96%	1.62%	1.93%	1.20%
Payout Ratio	71.06%	72.25%	45.72%	38.80%	41.90%	32.58%
Buyback Yield / Dilution	0.84%	-0.90%	0.83%	-3.50%	0.08%	2.56%
Total Shareholder Return	3.78%	2.64%	3.79%	-1.88%	2.00%	3.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.